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Audit to identify the prevalence of urinary incontinence in children 
and young adolescents attending the Cardiff Paediatric Cysfic 
Fibrosis Unit 
D. Rogers, K. Azzopardi, I.J.M. Doull  
Paediatric Cystic Fibrosis Unit, University Hospital of Wales (UHW), Cardiff 
In t roduct ion A number of studies have identified urinary incontinence as a cl inical 
problem ha both adult and paediatric ystic fibrosis (CF) patients. Recent studies 
have reported a prevalence of between 38% and 68% in all adult females with CF 
and a prevalence of between 4% and 64% in female patients with CF under 25 years 
of age. Recommendations for the physiotherapy management of CF in the UK state 
that it should be a cl inical standard to identify urinary incontinence in both adults 
and children with CF and then refer to an appropriate practitioner. 
Subjects mad Methods An  interview administered questionnaire was used to assess 
prevalence, severity mad impact of urinary incontinence ha both male and female 
paediatric patients over 5 years of age attending the CF clinic at the UHW Cardiff. 
The questionnaire was administered when patients attended for annual review and 
44 (83%) of 53 el igible children and adolescents (aged 5 20.5 years) participated ha 
the audit. 
Results 28 males and 16 female CF patients completed the questionnaire. Mean age 
13.4 years (range 5.5 20.5 years). 1 male patient (3.6%) and 7 female (43.7%) 
patients reported urinary incontinence as a current cl inical problem. The mean age 
of patients reporting symptoms was 15.5 years (range 10 18.7 years) 
Discussion Patient audit within our clinic population has identified a prevalence of 
urinary incontinence which is consistent with published ata. Results from this audit 
have informed and improved our annual assessment prccess and resulted ha 
specialist referral for affected patients. Further audit is required to determine i f  
identification mad intervention have resulted in any patients benefit. 
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What are the mechanisms that explain exercise capacity in adults 
with cystic fibrosis 
K.A. Blake 1, A.P. Freitag 1, K.J. Ki l l ian 1 
~McMaster University, Hamilto~ Ca uala 
Aims:  The aim was to identify and quantify the independent contribution of each 
mechanism and then construct an interdependent model to explain exercise 
intolerance ha this population. 
Methods:  77 adults with CF underwent comprehensive clinical exercise testing. 
Exercise capacity, anthropometric measures, CF genotype, B cepacia colonization, 
rest and exercise ventilation, respiratory muscle strength, gas transfer capacity, rest 
and exercise cardiovascular function, peripheral muscle strength and symptoms 
were evaluated as independent variables. The 3 largest contributors to exercise 
capacity, as determined by tmivariate analysis, were forced into the multiple 
regression analysis. Mult ip le linear regression analysis was used to evaluate mad 
quantify the significant contributors to exercise capacity. 
Results: Maximal  breathing capacity (R ~ 0.51), gas transfer capacity (R ~ 0.45) 
mad lower extremity peripheral muscle strength (R 2 0.48) consistently 
demonstrated the greatest independent contribution to exercise capacity (p<0.001) 
and were used to create a model of mechanisms l imit ing exercise performance. 
Other statistically significant (p<0.CO1) contributions were made by upper 
extremity peripheral muscle strength (R 2 0.34) mad maximal  exercising heart rate 
(R ~ 0.33); however, the magnitude of these contributions was noticeably less. No 
other measures made meaningful contributions to exercise capacity (p>0.05). The 
model of maximal  breathing capacity, gas transfer capacity and lower extremity 
peripheral muscle strength explained 65.5% of the variance seen in exercise 
capacity. 
Conclusions: Exercise capacity is diminished in adults with CF. Ventilation, gas 
transfer capacity and peripheral muscle strength are the key mechanisms that l imit 
exercise capacity in adults with CF. 
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Non invasive ventilafion (NIV) in patients with cystic fibrosis (CF) 
awaiting lung kansplantation (LT) 
M. Cornacchia, A. Zor zanello, L.M. Cappelletti, M. Donh, G. Placidi, C. Tar tali, L. 
Menin,  B .M. Assael, C. Br  aggion 
Cystic Fibrosis Center; Ospedale CiviIe Maggiore, l/~r na, Italy 
NIV may be used ha patients with CF wait ing for LT. The improvement of gas 
exchange and sleep efficiency due to nocturnal NIV would enable the stabilization 
of hypercapnic respiratory fai lure and the improvement of physical performance. 
Our experience in using NIV in patients with end stage CF lung disease is reported. 
21 patients (mean age 28 + 10 years), who had carbon dioxide tension i capillary 
blood (PcCO~) > 50 mmHg and used NIV during the night for at least 15 days were 
included. A bi level pressure support ventilator with nasal mask was used and 
oxygen was administered to obtain a oxygen saturation of haemoglobin between 92 
and 95%. The mean value of PcCO 2 was 62 + 11 mmHg at the beginning of NIV. 
19/21 patients were on a LT wait ing list. The mean duration of NIV support was 
220 + 230 days (range: 18 879 days). 14 patients underwent LT (mean wait ing 
t ime 263 + 210 days), 5 patients died whi le  awaiting LT and 2 patients were alive. 
PcCO~ showed a fast and significant increase (> 20 mmHg)  in the 5 patients who 
died. We observed either a gradual increase or a decrease in PcCO2 ha 14 patients, 
who received LT. Nasal bridge ulceration was recorded in 4 patients, who used NIV 
during both the night and the day. In 3/21 the treatment was not constant because of 
mask discomfort. In our experience NIV may be administered for a long period and 
may al low most patients to undergo LT. 
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High frequency chest compression (HFCC) therapy waveforms 
K. Solm, J.E. Holte, WJ .  Warwick 
Departments of Electrical a~u] Computer Engineering a~u] Pediatrics, University of 
Minnesota, Minneapolis, MN, USA 
Aims:  Al l  fllree wavefor ms (square, sine and triangle) used for HFCC therapy were 
developed in Minnesota but as yet no study anywhere has been attempted to 
compare how these waveforms transmit energy through the chest wal l  and the 
lungs. 
Methods:  We have used Sohn's computer model based on Weibel's airway model 
(Prc¢ 26th IEEE EMBS , 2CO4:3925 3928) to predict how the waveforms wi l l  
work on patients. The model used normal lung volumes for a 180 cm male. The 
computer model airf low at the mouth is a composite of normal breathing and the 
HFCC compression pulses. 
Observations: When the three waveforms were modeled at normal FRC the 
estimated effectiveness was greatest for the square and least for the tr iangle 
waveforms. When the model was changed so each waveform's effect on FRC 
during operation was entered into the model the estimated effectiveness was 
greatest for the tr iangle and least for the sine waveforms. These differences were not 
affected by the frequencies tested, the limitations of the sine waveform (from 5 to 
21 Hertz) were considered. 
Condusiolxs: As yet no one knows which wavefor m should be prescribed for which 
patient. Since HFCC was developed for respiratory airway clearance it is vital to 
study the optimal way to fit the "vest" should fit for HFCC, how to choose the 
waveform to prescribe, the frequencies to use, the duration of use for each 
frequency, the times per day for therapy and how long each therapy session should 
last. Some of these questions can be "solved" by computer modeling; the results of 
these predictions wi l l  have to be tested on patients. We wi l l  investigate the tbree 
waveforms, how each operates in our future researches to predict what human 
studies may f ind such as similarities mad differences between model and patients. 
